Cirdan key facts
as of Oct 2026- Developer of healthcare informatics software designed to offer imaging technology to accelerate and enhance diagnosis.
- Cirdan is valued at approximately $44.6M as of Oct 2026 (last reported valuation).
- It has raised $51.1M; the latest was Later Stage VC ($17.5M) in Mar 2026.
- Notable investors include Innovate UK, Salica Investments, Clarendon Fund Managers, Invest Northern Ireland, ABHI US Accelerator — 20 tracked in total.
- Status: Privately Held (backing).
Cirdan's last reported valuation, Oct 2024. Nothing priced has surfaced since.
- ·The complete investor list: 20 names
- ·Watch Cirdan: the Monday email on marks, rounds and moves
Cirdan funding rounds
No funding rounds for Cirdan are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Cirdan
20+Cirdan valuation
Cirdan's last reported valuation was $44.6 million in Oct 2024. No priced round, secondary trade or fund mark has surfaced since.
Cirdan investors
20 investors are on record for Cirdan, including Innovate UK, Salica Investments, Clarendon Fund Managers and Invest Northern Ireland.
About Cirdan
Developer of healthcare informatics software designed to offer imaging technology to accelerate and enhance diagnosis. The company's software offers the design and development of imaging sensors that are produced using X-ray, near-infrared, and visible light wavelengths in high-performance cameras, enabling healthcare professionals to make accurate diagnoses while improving efficiency across healthcare systems
- Sector
- Healthcare
- HQ
- Lisburn, United Kingdom
- Founded
- 2010
- Employees
- 121
- Website
- cirdan.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.